Anderson Hoagland & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $463K | Buy |
2,494
+60
| +2% | +$11.1K | 0.04% | 128 |
|
|
2025
Q1 | $428K | Hold |
2,434
| – | – | 0.05% | 121 |
|
|
2024
Q4 | $418K | Hold |
2,434
| – | – | 0.04% | 124 |
|
|
2024
Q3 | $473K | Sell |
2,434
-217
| -8% | -$42.2K | 0.05% | 118 |
|
|
2024
Q2 | $446K | Hold |
2,651
| – | – | 0.05% | 119 |
|
|
2024
Q1 | $448K | Buy |
2,651
+217
| +9% | +$36.7K | 0.05% | 115 |
|
|
2023
Q4 | $393K | Hold |
2,434
| – | – | 0.05% | 108 |
|
|
2023
Q3 | $363K | Buy |
+2,434
| New | +$363K | 0.05% | 112 |
|
|
2018
Q3 | – | Sell |
-11,875
| Closed | -$1.1M | – | 91 |
|
|
2018
Q2 | $1.1M | Hold |
11,875
| – | – | 0.61% | 56 |
|
|
2018
Q1 | $1.12M | Buy |
11,875
+4,770
| +67% | +$451K | 0.65% | 51 |
|
|
2017
Q4 | $687K | Buy |
+7,105
| New | +$687K | 0.4% | 75 |
|